Centers for Disease Control and Prevention Performance Evaluation program for Mycobacterium tuberculosis/Non-tuberculous Mycobacteria Drug Susceptibility Testing Program

Centers for Disease Control and Prevention Performance Evaluation Program for Mycobacterium Tuberculosis/Non-tuberculosis Mycobacteria Drug Susceptibility Testing Program

⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0920-0600 can be found here:

Documents and Forms

Document Name Document Type
Form Attachment #4 Centers for Disease Control and Prevention Performance Evaluation program for Mycobacterium tuberculosis/Non-tuberculous Mycobacteria Drug Susceptibility Testing Program Form
Attachment #4 Laboratory Enrollment Form #4 Enrollment Form.doc Form

Information Collection (IC) Details

IC Title:	Centers for Disease Control and Prevention Performance Evaluation program for Mycobacterium tuberculosis/Non-tuberculous Mycobacteria Drug Susceptibility Testing Program	Agency IC Tracking Number:

Is this a Common Form? No		IC Status: New

Obligation to Respond: Voluntary

CFR Citation:

Information Collection Instruments:

Document Type	Form No.	Form Name	Instrument File	URL	Available Electronically?	Can Be Submitted Electronically?	Electronic Capability
Form	Attachment #4	Laboratory Enrollment Form	#4 Enrollment Form.doc		Yes	Yes	Printable Only

Line of Business: Health

Subfunction: Public Health Monitoring

Privacy Act System of Records
Title:	FR Citation:

Number of Respondents: 2	Number of Respondents for Small Entity: 0

Affected Public: State, Local, and Tribal Governments

Percentage of Respondents Reporting Electronically: 50 %

	Approved	Program Change Due to Agency Discretion
Annual Number of Responses for this IC	2	2
Annual IC Time Burden (Hours)	0	0
Annual IC Cost Burden (Dollars)	0	0

Documents for IC

Title	Document	Date Uploaded
No associated records found

Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.